WeChat Mini Program
Old Version Features

Safety and Tolerability of Immunosuppression in Non-Ipf ILD: Clinical Experience from a Tertiary ILD Centre

EUROPEAN RESPIRATORY JOURNAL(2019)

Cited 0|Views41
Key words
Idiopathic pulmonary fibrosis,Treatments,Immunosuppression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined